Dynavax Technologies | Nettoinkomst



Net Income Ändra Datum
AbbVie USD -22000000 1.58B 2024-12
Adma Biologics USD 111.9M 75.99M 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Dynavax Technologies USD 7.05M 10.54M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Merck USD 3.74B 586M 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
TG Therapeutics USD 23.33M 19.45M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Dynavax Technologies Nettoinkomst - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.